CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Biohaven trades cash for ‘upside’ with $795M epilepsy drug deal

Read the original article

Published by BioPharma Dive on August 26, 2026 3:17 PM

Read Original